Improving Patient Care Since 1979
REFERENCES:
Am J Cardiol. 2006 Mar 1;97(5):640-5.
http://www.ncbi.nlm.nih.gov/pubmed/16490429
Dis Markers. 2008;24(6):341-9.
http://www.ncbi.nlm.nih.gov/pubmed/18688083
Int J Cardiol. 2006 Nov 10;113(2):167-73.
http://www.ncbi.nlm.nih.gov/pubmed/16338010
Arterioscler Thromb Vasc Biol. 2001;21:844-848.
https://lirias.kuleuven.be/bitstream/123456789/12499/1/12499_844.pdf
Dr. Ladd McNamara
www.laddmcnamara.net
Mercodia
www.mercodia.com
Holvoet et al. (1996) Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure. Thromb Haemostasis 76:663-669
http://www.ncbi.nlm.nih.gov/pubmed/8950769
Holvoet et al. (1998) Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 98:1487-1494
http://www.ncbi.nlm.nih.gov/pubmed/9769301
Holvoet et al. (2002) Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the health, aging, and body composition study. Arterioscler Thromb Vasc Biol23:1444-1448 http://www.ncbi.nlm.nih.gov/pubmed/12791672
Holvoet (2004) Oxidized LDL and coronary heart disease. Acta Cardiol 59: 479-484
http://www.ncbi.nlm.nih.gov/pubmed/15529550
Huang et al. (1999) Oxidized LDL stimulates matrix metalloproteinase-1 expression in human vascular endothelial cells. Arterioscler Thromb Vasc Biol 19:2640-2647
http://www.ncbi.nlm.nih.gov/pubmed/10559006
Johnston et al. (2006) Improved identification of patients with coronary artery disease by the use of new lipid and lipoprotein biomarkers. Am J Cardiol 97:640-645
http://www.ncbi.nlm.nih.gov/pubmed/16490429
Johnston et al. (2006) Oxidized low-density lipoprotein as a predictor of outcome in patients with unstable coronary artery disease. Int J Cardiol 113:167-173
http://www.ncbi.nlm.nih.gov/pubmed/16338010
Kopprasch et al. (2002) In Vivo Evidence for Increased Oxidation of Circulating LDL in Impaired Glucose Tolerance.Diabetes 51:3102-3106
http://www.ncbi.nlm.nih.gov/pubmed/12351454
Meisinger et al. (2005) Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 112:651-657
http://www.ncbi.nlm.nih.gov/pubmed/16043640
Sigurdardottir et al. (2002) Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study). J Internal Med 252:440-447
http://www.ncbi.nlm.nih.gov/pubmed/12528762
Wallenfeldt et al. (2002) Oxidized low-density lipoprotein in plasma is a prognostic marker of subclinical atherosclerosis development in clinically healthy men. J Internal Medicine 256:413-420
http://www.ncbi.nlm.nih.gov/pubmed/15485477
Young and McEneny (2001) Lipoprotein oxidation and atherosclerosis. Biochem Soc Trans 29:358-36Ω
www.ncbi.nlm.nih.gov/pubmed/11356183
Lab tests are among the best indicators for detecting chronic disease.
Checking your Oxidized LDL cholesterol, along with your routine lipid profile, will help determine your true risk for heart disease and stroke.
With accurate information, you can make decisions with your physician that can help you reduce your risk of chronic disease.
Lab Tests Provide an accurate Method To Assess Your True Health Status.
The Benefits of Optimal Health Panels!
Optimal Health Panels are affordable blood tests that can help identify deficiencies that could lead to chronic disease.
Starting with a baseline, you can improve the state of your health by making healthy lifestyle changes, with the possibility of reducing your risk of chronic disease.
Improving Patient Care Since 1979
CMB is a pioneer in developing new diagnostic technologies to address unmet medical needs and improve patient care. The laboratory offers clinical assays, ranging from routine blood analyses to HIV and genomic testing. We pride ourselves on our quality service to patients, physicians, hospitals, and pharmaceutical companies.